By Tim Stephens, Kimothy Smith and David Olive
Talks of denuclearizing North Korea may create the momentum for a new method of addressing the frightening growth of chemical and biological weapons around the world.
By James M Wilson and Kimothy L. Smith
Concerns are growing over word that NBIC is being considered for programmatic cancellation by DHS’ newly formed Combatting Weapons of Mass Destruction Directorate.
There is a long list of things in the homeland security arena that remain undone as the Trump Administration begins its second full year.
The rhetoric from DHS leadership about the overwhelming need for cybersecurity talent, as well as other stated priorities, does not match the reality of the DHS FY18 budget proposal.
By Tim Stephens
A missing element in existing border security measures is a means to ensure we don’t increase the threat from disease outbreaks.
DHS Secretary Jeh Johnson’s final “State of Homeland Security” talk included the usual reference to his “Unity of Effort” initiative. While his intentions are good, within DHS, the effort is viewed as nothing more than a “Unity of Rhetoric” initiative. Here are several ways well-meaning ideas have fallen well-short of reality.
The recent House Homeland Security Committee’s hearing on the threat from bioterrorism raised the troubling threat that drones could be used to deliver deadly pathogens. Do we have the tools to detect biological agents and the drones that might carry them? Nope.
The Blue Ribbon Study Panel on Biodefense recently released its report following a year-long study of how America can and should address biological threats. It deserves serious attention by policy makers, health practitioners and political pundits. Why? Because the threat and impact of a biological “event” is not receiving sufficient attention.
For the past few months, a Blue Ribbon Panel on Biodefense has been receiving input from industry and policy experts on the challenges America faces from the bio-related threats. The public testimony portion of their assignment recently concluded, and now the Panel will begin its review and recommendation work.
The first person to be diagnosed with Ebola on U.S. soil has died. The case of Thomas Eric Duncan, coupled with the fact that there is no known cure or vaccine for Ebola, raises questions about the threat from bioterrorism.
Sponsored by:
